Home › Funds › Weaver C. Barksdale & Associates, Inc. › CI
Weaver C. Barksdale & Associates, Inc. position in CI
THE CIGNA GROUP · Health Care
Weaver C. Barksdale & Associates, Inc. reported holding 6,431 shares of CI (THE CIGNA GROUP) in its Q3 2026 13F filing — a position valued at US$1.7M, representing 1.60% of its reported portfolio and ranking #36 among its reported holdings. Weaver C. Barksdale & Associates, Inc. has disclosed CI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Weaver C. Barksdale & Associates, Inc.'s CI position evolved
Weaver C. Barksdale & Associates, Inc. first disclosed a stake in CI in Q3 2023 at 1,859 shares (US$532K). The position peaked in Q2 2026 at 6,654 shares, worth US$1.8M. Across 13 filings, Weaver C. Barksdale & Associates, Inc. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 6,431 shares valued at US$1.7M — a reduction of -223 shares quarter over quarter.. Notable position changes include a 202% increase in Q4 2025 (shares fell 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.86K | $531.80K | New |
| Q4 2023 | 1.86K | $556.68K | Hold |
| Q1 2024 | 1.86K | $675.17K | Hold |
| Q2 2024 | 1.86K | $614.53K | Hold |
| Q3 2024 | 1.86K | $644.03K | Hold |
| Q4 2024 | 1.86K | $513.34K | Hold |
| Q1 2025 | 1.86K | $611.61K | Hold |
| Q2 2025 | 2.08K | $685.95K | Add |
| Q3 2025 | 2.08K | $598.12K | Hold |
| Q4 2025 | 6.28K | $1.73M | Add |
| Q1 2026 | 6.69K | $1.79M | Add |
| Q2 2026 | 6.65K | $1.83M | Reduce |
| Q3 2026 | 6.43K | $1.75M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CI and 13F data
CI (THE CIGNA GROUP) is a Health Care company. 22 other funds we track also report a position in CI — the largest reported positions include Dodge & Cox (US$3.36B), DODGE & COX (US$3.36B), Sanders Capital, LLC (US$2.74B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CI
- Dodge & Cox 12.17M sh · $3.36B · Q2 2026
- DODGE & COX 12.17M sh · $3.36B · Q2 2026
- Sanders Capital, LLC 10.10M sh · $2.74B · Q3 2026
- MFS Investment Management 9.74M sh · $2.67B · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 2.60M sh · $706.60M · Q3 2026
More on Weaver C. Barksdale & Associates, Inc.
FAQ
How long has Weaver C. Barksdale & Associates, Inc. held CI?
Weaver C. Barksdale & Associates, Inc. has disclosed CI holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Weaver C. Barksdale & Associates, Inc.'s current position in CI?
As of Q3 2026, Weaver C. Barksdale & Associates, Inc. holds 6.43K shares of CI (THE CIGNA GROUP), valued at $1.75M, representing 1.60% of its reported portfolio and ranking #36.
Has Weaver C. Barksdale & Associates, Inc. been buying or selling CI?
In the latest 13F filing (Q3 2026), Weaver C. Barksdale & Associates, Inc. reduced its position in CI. The position peaked in Q2 2026 at 6.65K shares.
Which other funds hold CI?
Other major institutional holders of CI include Dodge & Cox, DODGE & COX, Sanders Capital, LLC, among 22 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.